High-end Cellomics Market
Market Insights on High-end Cellomics covering sales outlook, demand forecast & up-to-date key trends
High-end Cellomics Market by Application (Academic Research/Basic Research, Drug Discovery (Primary & Secondary Screening, Target Identification & Validation, Invitro Toxicity Studies, Compound Profiling), End User & Region, Forecast 2021 - 2031
High-end Cellomics Market Snapshot
[216 Pages Report] The High-end Cellomics Market revenue totaled US$ 288.8 Mn in 2021, according to Future Market Insights (FMI) study. The overall sales of high-end cellomics are expected to reach US$ 536.9 Mn by 2031, at a CAGR of 6.4% for 2021 - 2031.
High-end Cellomics allows analyzing how compound interacts with the target at the subcellular level, which delivers insights that can drive go/no-go decisions. Recent developments in drug discovery and high-end cellomics have augmented pressure at the strategic points along the drug discovery pipeline.
Thus, the rising need to determine and study toxicity levels in the initial phase of drug discovery is driving the market growth. The demand for drug discovery also will grow, accounting for nearly 55% of high-end Cellomics revenue in 2021. As per FMI, the high-end Cellomics market represented 1% to 2% of overall sales in US$ 21.09 Bn worth high throughput screening market in 2020.
Market Outlook:
|
Data Points |
Market Insights |
|
High-end Cellomics Market Value 2020 |
US$ 273.9Mn |
|
Estimated High-end Cellomics Market Value 2021 |
US$ 288.8Mn |
|
CAGR 2021-2031 |
6.4% |
|
Key Players |
PerkinElmer Inc., Molecular Devices LLC (Danaher Corporation LLC), Thermofisher Scientific and Yokagawa Electric Corporatoin |
Let us know your requirement to get
100% FREE customization
2016-2020 High-end Cellomics Demand Outlook Compared to 2021-2031 Forecast
According to Future Market Insights (FMI), the sales of high-end cellomics have grown at a CAGR of 6.4% during 2021- 2031. Due to the rising prevalence of several genetic disorders and neurological diseases, the demand for effective screening methods and techniques has increased in the last decade. This had a positive impact on the high-end cellomics market.
Initiatives undertaken by governments to promote advanced research in biotechnology will increase installation of high-end cellomics instruments for drug discovery applications. Cities of India such as Bangalore, Pune, Hyderabad, and Tamil Nadu have well-established biotechnology research infrastructure recognized globally, which will drive the demand for high-end research instruments.
Apart from India, China, and the U.S., governments of Japan, Brazil, the U.K., and Australia are supporting their domestic biotechnology and bioscience industry through similar initiatives. Factors such as these are expected to create lucrative growth opportunities for manufacturers operating in the global high-end cellomics market
How will Development of Advanced Imaging Systems Augment High-end Cellomics Market Growth?
High-end cellomics has recently acquired substantial traction due to its capacity to investigate features across numerous parts of cell biology and drug discovery and development process. Because of their increased application in life sciences research, these systems have seen technological breakthroughs in automated microscope hardware, sCMOS cameras, confocal optics, oil immersion objective lenses, and throughput capabilities.
Furthermore, these systems have increased software data analysis and data management capabilities. Considering these advancements, the industry players are focusing on introducing new products with these features. Some of the recent launches in this regard include:
In January 2021, Molecular Devices LLC introduced a new high content screening system – ImageXpress Confocal HT.ai High Content HT.ai. This device enables researchers to accelerate their study on phenotypic screening of organoid models. Quick Image acquisition and multiplexing flexibility with high performing lasers are some of the benefits offered by this next-generation high content screening system.
Molecular Devices LLC, in December 2020, introduce water imaging technology for the ImageXpress Micro Confocal High-Content Imaging System. This latest system is developed on existing 3D imaging technology which enables acquisition and analysis of both 3D cell model assays such as spheroids, organoids, and organ-on-chip biology
Availability of such innovative products with associated benefits will lead to an increase adoption, thus fueling the growth of the global high-end cellomics market.
What are the Key Opportunities for High-end Cellomics Market Players?
High-end cellomics systems are used across a wide range of applications in drug discovery including primary and secondary screening, target identification and validation, toxicity testing, and compound profiling.
For pharmaceutical and biotechnology companies, which is one of the major end-users of these systems, having high-end high content screening equipment increases the total R&D cost of drug development. Also, budgetary constraints among the academic and research institutes lowers the adoption rate of the high-end cellomics systems.
These end-users prefer to outsource HCS services to independent contract research organizations (CROs), due to which the number of CROs offering these services is rising. Charles River Laboratories, Eurofins international are some of the CROs offering high-end cellomics services. Thus, the growing interest in outsourcing services is anticipated to positively drive the sales of the high-end cellomics systems, which in turn provides a lucrative opportunity for market growth.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWill the High Cost of High-end Cellomics Instruments Lower their Adoption?
A high-end cellomics instrument is a set of various analytical methods including automated microscopy, image processing, and visualization tools in one single system. Also, these systems have improved features such as high throughput capacity, confocal optics, sCMOS cameras, water, and oil immersion lens. Hence they are priced on the higher-end.
Apart from the instrumentation cost, installation, maintenance and services costs also add up to the total cost of ownership, thus leading to an increase in the total spending. Academic research institutes, CROS, pharmaceutical and biotechnology companies who are the primary end-users of these systems, are sometimes reluctant for adoption owing to budgetary constraints.
This has made them shift towards other cell imaging analysis equipment such as cell imaging instruments and flow cytometry. This trend is particularly seen in the price-sensitive markets such as India. Thus, the high cost of these instruments coupled with the availability of alternative instruments is expected to create a negative impact on the market growth.
What is the Impact of the COVID-19 Crisis on the Market?
With this unprecedented crisis, the healthcare industry has found itself on the frontline to deal with the medical emergency which has not only ruined the economies across the globe but has also put huge pressure on the healthcare facilities.
The unexpected level of request for the testing kits has pushed the industry players into unexplored regions where their assets are confronted on regular basis. In addition to this, the supplies and demands were jolted by the massive infection spread, which staggered the supplies for manufacturing the high-end cellomics market.
As high-end cellomics instruments are used only for research purposes, the temporary halt in research and development activities has created a sharp reduction in demand for these products. Thus, the high-end cellomics market is expected to witness a short-term negative impact on market growth.
With the lifting of lockdown, reopening of the companies and industries, resuming research and development activities in cell-based research and drug discovery, government initiatives and reviewed market approaches, the high-end cellomics market will register increasing growth 2021 onwards.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
Will the U.S. Remain a Key High-end Cellomics Market?
In 2021, the U.S. high-end cellomics market will account for over 86% value share in North America. Demand in the U.S. is primarily driven by a strong regional economy, the presence of refined research and healthcare facilities, and improved attention on overall health and wellbeing.
How will Germany High-end Cellomics Market Fare?
Germany is expected to account for over 21% of the Europe market in 2031. Growing capital and venture investments for cellular research, technological developments in high-end cellomics solutions, cost restraint in pharma R&D, and the presence of key players have led resulted in high growth of the Germany market.
What are the Factors Supporting High-end Cellomics Sales in Australia?
The Australia market will exhibit a 5.0% CAGR throughout the forecast period. The rising prevalence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s is one of the key factors driving the market growth. Similarly, the growing geriatric population is supplementing market growth in Australia.
What will Drive Demand in India High-end Cellomics Market?
The India market account for more than 67% of the sales registered in the South Asia region in 2021. Research activities in the biotechnology and bioscience field are increasing rapidly due to government support and the availability of funds, thus increasing the demand for high-end cellomics in India.
The Government of India is offering 100% foreign direct investment for biotechnology companies that are based outside India, and the GOI is offering public-private partnerships for the companies based in India. Also, the Department of Biotechnology has supported the biotechnology research infrastructure including high-end high content screening system, flow cytometry, imaging microarray, and high-resolution mass spectrometry facilities in Delhi and Mumbai respectively.
What is the Scope for Sales of High-end Cellomics in China?
The market for high-end cellomics in China is exhibiting 7.1% CAGR and is expected to account for 82% of the East Asia market in 2031. Government initiatives to spur biotechnology industry in the region is creating growth opportunities in China. China has included the biotechnology industry as one of the strategic priorities for development in terms of technology. Also, there were about 95 biotech-related deals till June 2020, drawing about USD 12 billion of deals. In 2020, Everest Medicines Ltd and Maxwell Biosciences Co. Ltd. raised USD 310 million in June and USD 279 million respectively. These companies have strong oncology and immunology products in their pipelines, which will require advanced instrumentation such as high-end HCS systems in the drug discovery phase for screening and compound profiling.
Category-wise Insights
What are the Sales Prospects in Drug Discovery?
High-end cellomics demand in drug discovery will consistently rise, registering a high share of 55% in 2021. Increasing support for research and development activities, particularly for rare diseases, and the growing use of informatics in drug discovery led to demand for Drug Discovery.
Why is Demand for High-end Cellomics High in Pharmaceutical & Biotechnology Companies?
Pharmaceutical & biotechnology companies are currently leading the market. Demand in the pharmaceutical & biotechnology companies is expected to grow by 6.2% CAGR. Pharmaceutical & biotechnology companies are using this informatics software widely for pre-clinical research & development, compound screening and lead documentation, target identification, and rationalization of their drug discovery process which is the key factor for propelling the growth of the Pharmaceutical & Biotechnology Companies segment.
Competitive Landscape
Leading players are primarily focusing on market consolidation activities such as mergers, acquisitions, supply distribution partnerships, and launching new products, leading to high competitiveness in this space.
To capitalize on the growing market opportunity, market players are actively focusing on developing high-end cellomics instruments. These systems have increased software data analysis and data management capabilities. Quick image acquisition and multiplexing flexibility with high performing lasers and improved incubation environment are some of the benefits offered by these systems.
ImageXpress Confocal HT.ai High Content HT.ai. (Molecular Devices LLC), ImageXpress Micro Confocal High-Content Imaging System (with water imaging technology)(Molecular Devices LLC), Cell Voyager CV8000 (Yokogawa) are some of the recent launches by the industry players in the global high-end cellomics market.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value. |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
|
Key Segments Covered |
Application, End-User, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
High-end Cellomics Market by Category
Application:
- Academic Research/Basic Research
- Drug Discovery
- Primary & Secondary Screening
- Target Identification & Validation
- Invitro Toxicity Studies
- Compound Profiling
End-User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Independent Contract Research Organizations (CROs)
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Frequently Asked Questions
The high-end cellomics market will reach US$ 288.8 Mn in the year 2021 and is expected to surpass US$ 536.9 Mn by 2031.
High-end cellomics market is projected to register a CAGR of 6.4% during 2021-2031.
Growing Investments in cell-based research activities, development of advanced imaging systems, increasing applications in cellular disease modelling systems and growing interest in image-based high content screening are some of the prominent trends which drive the demand for high-end cellomics
The extensive research and development in drug discovery and are the chief driving factors.
The cumulative market share of the top players including PerkinElmer Inc. and Molecular Devices LLC (Danaher Corpoartion LLC) Corporation constitutes around 88.5% of the overall fragmented market.
U.S., China, India, Germany and UK are the top 5 countries that are driving the demand for
Europe will hold around 30% revenue share in the overall High-end Cellomics Market in 2021. Germany remains the fastest growing country in the Europe market, exhibiting a CAGR of 7.2% over the forecast period of 2021-2031.
The East Asia market is set to exhibit a CAGR of 6.9% during 2021-2031, the forecast period owing to the continuous research and development in the field of biotechnology which is driving the introduction of innovative and breakthrough technologies, thereby expanding the application areas of biotechnology tools in the region.
PerkinElmer, Inc., ThermoFisher Scientific, Inc., Molecular Devices LLC (part of Danaher Corporation) and Yokogawa Electric Corporation are the key manufacturers.
Japan high-end cellomics market is expected to account for 10% of global sales through 2031. South Korea will account for 8% of total share through the end of the assessment period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion & Exclusion
3. Key Trends
3.1. Key Trends Impacting the Market
3.2. Trends in Diverse Application
4. Key Success Factors
4.1. Key Products USP Analysis
4.2. Key Manufacturers Promotional Strategies
4.3. Value Chain Analysis
4.4. PESTLE Analysis
4.5. PORTERS Analysis
4.6. Key Regulations
5. Market Background
5.1. Macro-Economic Factors
5.1.1. GDP Growth Outlook
5.1.2. Global Healthcare Industry Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Players Historic Growth
5.2.2. Extensive Research & Development Activities
5.2.3. New Product Launches & Approvals
5.2.4. Growing Funding for Biotechnology/Life Science Sector
5.2.5. Rise in uptake of advanced High-end Cellomics Market
5.2.6. Growing R&D activities by Key Players
5.2.7. Product Adoption
5.2.8. Key Strategic Developments
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. COVID19 and Impact Analysis
6.4. 2020 Market Scenario
6.5. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global High-end Cellomics Market - Pricing Analysis
7.1. Country Pricing Analysis by Product Type
7.2. Global Average Pricing Analysis Benchmark
8. Global High-end Cellomics Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031
8.1. Historical Market Volume (Units) Analysis, 2016-2020
8.2. Current and Future Market Volume (Units) Projections, 2021-2031
8.2.1. Y-o-Y Growth Trend Analysis
9. Global High-end Cellomics Market Value Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Application, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021-2031
10.3.1. Academic Research/Basic Research
10.3.2. Drug Discovery
10.3.2.1. Primary & Secondary Screening
10.3.2.2. Target Validation & Identification
10.3.2.3. Toxicity Studies
10.3.2.4. Compound Profiling
10.4. Market Attractiveness Analysis by Application
11. Global High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by End User, 2016-2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2021-2031
11.3.1. Pharmaceutical & Biotechnology Companies
11.3.2. Academic Research Institutes
11.3.3. Independent Contract Research Organizations (CROs)
11.4. Market Attractiveness Analysis by End User
12. Global High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. North America High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Application
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.2. By Application
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. Rest of Europe
15.3.2. By Application
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Singapore
16.3.1.3. Thailand
16.3.1.4. Indonesia
16.3.1.5. Malaysia
16.3.2. By Application
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.1.4. Rest of East Asia
17.3.2. By Application
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Application
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa High-end Cellomics Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Rest of Middle East and Africa
19.3.2. By Application
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Key and Emerging Countries High-end Cellomics Market Analysis 2021 & 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. U.S. High-end Cellomics Market Analysis
20.2.1. By Application
20.2.2. By End User
20.3. Canada High-end Cellomics Market Analysis
20.3.1. By Application
20.3.2. By End User
20.4. Brazil High-end Cellomics Market Analysis
20.4.1. By Application
20.4.2. By End User
20.5. Mexico High-end Cellomics Market Analysis
20.5.1. By Application
20.5.2. By End User
20.6. U.K. High-end Cellomics Market Analysis
20.6.1. By Application
20.6.2. By End User
20.7. Germany High-end Cellomics Market Analysis
20.7.1. By Application
20.7.2. By End User
20.8. France High-end Cellomics Market Analysis
20.8.1. By Application
20.8.2. By End User
20.9. Italy High-end Cellomics Market Analysis
20.9.1. By Application
20.9.2. By End User
20.10. Spain High-end Cellomics Market Analysis
20.10.1. By Application
20.10.2. By End User
20.11. BENELUX High-end Cellomics Market Analysis
20.11.1. By Application
20.11.2. By End User
20.12. Russia High-end Cellomics Market Analysis
20.12.1. By Application
20.12.2. By End User
20.13. China High-end Cellomics Market Analysis
20.13.1. By Application
20.13.2. By End User
20.14. Japan High-end Cellomics Market Analysis
20.14.1. By Application
20.14.2. By End User
20.15. South Korea High-end Cellomics Market Analysis
20.15.1. By Application
20.15.2. By End User
20.16. India High-end Cellomics Market Analysis
20.16.1. By Application
20.16.2. By End User
20.17. Singapore High-end Cellomics Market Analysis
20.17.1. By Application
20.17.2. By End User
20.18. Thailand High-end Cellomics Market Analysis
20.18.1. By Application
20.18.2. By End User
20.19. Malaysia High-end Cellomics Market Analysis
20.19.1. By Application
20.19.2. By End User
20.20. Indonesia High-end Cellomics Market Analysis
20.20.1. By Application
20.20.2. By End User
20.21. Australia High-end Cellomics Market Analysis
20.21.1. By Application
20.21.2. By End User
20.22. New Zealand High-end Cellomics Market Analysis
20.22.1. By Application
20.22.2. By End User
20.23. GCC Countries High-end Cellomics Market Analysis
20.23.1. By Application
20.23.2. By End User
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Market Share Analysis of Top Players
21.4. Brand Share Analysis, By Key Brands
21.5. Competition Deep Dive
21.5.1. PerkinElmer, Inc.
21.5.1.1.1. Overview
21.5.1.1.2. Product Portfolio
21.5.1.1.3. Analyst Commentary
21.5.1.1.4. Key Financials
21.5.1.2. Recent Developments
21.5.1.3. Sales Footprint
21.5.1.4. Strategy Overview
21.5.1.4.1.1. Marketing Strategy
21.5.1.4.1.2. Product Strategy
21.5.1.4.1.3. Channel Strategy
21.5.2. Molecular Devices LLC (Danaher Corporation)
21.5.2.1.1. Overview
21.5.2.1.2. Product Portfolio
21.5.2.1.3. Analyst Commentary
21.5.2.1.4. Key Financials
21.5.2.2. Recent Developments
21.5.2.3. Sales Footprint
21.5.2.4. Strategy Overview
21.5.2.4.1.1. Marketing Strategy
21.5.2.4.1.2. Product Strategy
21.5.2.4.1.3. Channel Strategy
21.5.3. ThermoFisher Scientific
21.5.3.1.1. Overview
21.5.3.1.2. Product Portfolio
21.5.3.1.3. Analyst Commentary
21.5.3.1.4. Key Financials
21.5.3.2. Recent Developments
21.5.3.3. Sales Footprint
21.5.3.4. Strategy Overview
21.5.3.4.1.1. Marketing Strategy
21.5.3.4.1.2. Product Strategy
21.5.3.4.1.3. Channel Strategy
21.5.4. Yokogawa Electric Corporation
21.5.4.1.1. Overview
21.5.4.1.2. Product Portfolio
21.5.4.1.3. Analyst Commentary
21.5.4.1.4. Key Financials
21.5.4.2. Recent Developments
21.5.4.3. Sales Footprint
21.5.4.4. Strategy Overview
21.5.4.4.1.1. Marketing Strategy
21.5.4.4.1.2. Product Strategy
21.5.4.4.1.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global High-end Cellomics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 02: Global High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 03: Global High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 04: Global High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 05: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 06: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 07: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 08: Latin America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 09: North America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 10: Latin America High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 11: Europe High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 12: Europe High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 13: Europe High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 14: South Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 15: South Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 16: South Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 17: East Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 18: East Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 19: East Asia High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 20: Oceania High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 21: Oceania High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 22: Oceania High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 23: MEA High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 24: MEA High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 25: MEA High-end Cellomics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global High-end Cellomics Market Revenue Share by Application, 2021E & 2031F
Figure 02: Global High-end High Content Screening System Market Revenue Share by End User, 2021E & 2031F
Figure 03: Global Average Pricing Analysis Benchmark USD (Unit) (2020)
Figure 04: Global High-end Cellomics Market Historical Market Volume (Units) Analysis, 2016-2020
Figure 05: Global High-end Cellomics Market Volume (Units), 2021-2031 & Y-o-Y Growth Trend Analysis
Figure 06: Global High-end Cellomics Market Historical Market Value (US$ Mn) Analysis, 2016-2020
Figure 07: Global High-end Cellomics Market Value (US$ Mn), 2021-2031 & Y-o-Y Growth Trend Analysis
Figure 08: Global High-end Cellomics Market Absolute $ Opportunity, 2021–2031
Figure 09: Global High-end Cellomics Market Share Analysis (%) By Application, 2021 & 2031
Figure 10: Global High-end Cellomics Market Y-o-Y Growth (%) By Application, 2021-2031
Figure 11: Global High-end Cellomics Market Attractiveness Analysis, By Applications
Figure 12: Global High-end Cellomics Market Share Analysis (%) By End User, 2021 & 2031
Figure 13: Global High-end Cellomics Market Y-o-Y Growth (%) By End User, 2021-2031
Figure 14: Global High-end Cellomics Market Attractiveness Analysis, By End User
Figure 15: Global High-end Cellomics Market Share Analysis (%) By Region, 2021 & 2031
Figure 16: Global High-end Cellomics Market Y-o-Y Growth (%) By Region, 2021-2031
Figure 17: Global High-end Cellomics Market Attractiveness Analysis, By Region
Figure 18: North America High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020
Figure 19: North America High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 20: North America High-end Cellomics Market Share, By Application (2021)
Figure 21: North America High-end Cellomics Market Share, By End User (2021)
Figure 22: North America High-end Cellomics Market Share, By Region (2021)
Figure 23: North America High-end Cellomics Market Attractiveness Analysis, By Application
Figure 24: North America High-end Cellomics Market Attractiveness Analysis, By End User
Figure 25: North America High-end Cellomics Market Attractiveness Analysis, By Country
Figure 26: Latin America High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020
Figure 27: Latin America High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 28: Latin America High-end Cellomics Market Share, By Application (2021
Figure 29: Latin America High-end Cellomics Market Share, By End User (2021)
Figure 30: Latin America High-end Cellomics Market Share, By Region (2021)
Figure 31: Latin America High-end Cellomics Market Attractiveness Analysis, By Application
Figure 32: Latin America High-end Cellomics Market Attractiveness Analysis, By End User
Figure 33: Latin America High-end Cellomics Market Attractiveness Analysis, By Country
Figure 34: Europe High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020
Figure 35: Europe High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 36: Europe High-end Cellomics Market Share, By Application (2021)
Figure 37: Europe High-end Cellomics Market Share, By End User (2021)
Figure 38: Europe High-end Cellomics Market Share, By Region (2021
Figure 39: Europe High-end Cellomics Market Attractiveness Analysis, By Application
Figure 40: Europe High-end Cellomics Market Attractiveness Analysis, By End User
Figure 41: Europe High-end Cellomics Market Attractiveness Analysis, By Country
Figure 42: South Asia High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020
Figure 43: South Asia High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 44: South Asia High-end Cellomics Market Share, By Application (2021)
Figure 45: South Asia High-end Cellomics Market Share, By End User (2021)
Figure 46: South Asia High-end Cellomics Market Share, By Region (2021)
Figure 47: South Asia High-end Cellomics Market Attractiveness Analysis, By Application
Figure 48: South Asia High-end Cellomics Market Attractiveness Analysis, By End User
Figure 49: South Asia High-end Cellomics Market Attractiveness Analysis, By Country
Figure 50: East Asia High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020
Figure 51: East Asia High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 52: East Asia High-end Cellomics Market Share, By Application (2021)
Figure 53: East Asia High-end Cellomics Market Share, By End User (2021)
Figure 54: East Asia High-end Cellomics Market Share, By Region (2021)
Figure 55: East Asia High-end Cellomics Market Attractiveness Analysis, By Application
Figure 56: East Asia High-end Cellomics Market Attractiveness Analysis, By End User
Figure 57: East Asia High-end Cellomics Market Attractiveness Analysis, By Country
Figure 58: Oceania High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020
Figure 59: Oceania High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 60: Oceania High-end Cellomics Market Share, By Application (2021)
Figure 61: Oceania High-end Cellomics Market Share, By End User (2021)
Figure 62: Oceania High-end Cellomics Market Share, By Region (2021)
Figure 63: Oceania High-end Cellomics Market Attractiveness Analysis, By Application
Figure 64: Oceania High-end Cellomics Market Attractiveness Analysis, By End User
Figure 65: Oceania High-end Cellomics Market Attractiveness Analysis, By Country
Figure 66: MEA High-end Cellomics Market Value (US$ Mn) Analysis, 2016–2020
Figure 67: MEA High-end Cellomics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021-2031
Figure 68: MEA High-end Cellomics Market Share, By Application (2021)
Figure 69: MEA High-end Cellomics Market Share, By End User (2021)
Figure 70: MEA High-end Cellomics Market Share, By Region (2021)
Figure 71: MEA High-end Cellomics Market Attractiveness Analysis, By Application
Figure 72: MEA High-end Cellomics Market Attractiveness Analysis, By End User
Figure 73: MEA High-end Cellomics Market Attractiveness Analysis, By Country
Figure 74: Global Vs. U.S. Growth Comparison
Figure 75: U.S. High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 76: U.S. High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 77: Global Vs. Canada Growth Comparison
Figure 78: Canada High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 79: Canada High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 80: Global Vs. Brazil Growth Comparison
Figure 81: Brazil High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 82: Brazil High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 83: Global Vs. Mexico Growth Comparison
Figure 84: Mexico High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 85: Mexico High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 86: Global Vs. U.K. Growth Comparison
Figure 87: U.K. High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 88: U.K. High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 89: Global Vs. Germany Growth Comparison
Figure 90: Germany High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 91: Germany High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 92: Global Vs. Italy Growth Comparison
Figure 93: Italy High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 94: Italy High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 95: Global Vs. France Growth Comparison
Figure 96: France High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 97: France High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 98: Global Vs. Spain Growth Comparison
Figure 99: Spain High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 100: Spain High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 101: Global Vs. BENELUX Growth Comparison
Figure 102: BENELUX High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 103: BENELUX High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 104: Global Vs. Russia Growth Comparison
Figure 105: Russia High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 106: Russia High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 107: Global Vs. India Growth Comparison
Figure 108: India High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 109: India High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 110: Global Vs. Singapore Growth Comparison
Figure 111: Singapore High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 112: Singapore High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 113: Global Vs. Thailand Growth Comparison
Figure 114: Thailand High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 115: Thailand High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 116: Global Vs. Malaysia Growth Comparison
Figure 117: Malaysia High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 118: Malaysia High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 119: Global Vs. China Growth Comparison
Figure 120: China High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 121: China High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 122: Global Vs. Japan Growth Comparison
Figure 123: Japan High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 124: Japan High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 125: Global Vs. South Korea Growth Comparison
Figure 126: South Korea High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 127: South Korea High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 128: Global Vs. Australia Growth Comparison
Figure 129: Australia High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 130: Australia High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 131: Global Vs. New Zealand Growth Comparison
Figure 132: New Zealand High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 133: New Zealand High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Figure 134: Global Vs. GCC Countries Growth Comparison
Figure 135: GCC Countries High-end Cellomics Market Analysis (%) By Application, 2021 & 2031
Figure 136: GCC Countries High-end Cellomics Market Analysis (%) By End User, 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
